The Food and Drug Administration wants more men included in breast cancer drug trials.
Men make up about one percent of breast cancer cases, however, they're likely to be diagnosed at a more advanced stage.
Few men have been included in past trials, so there's very little data on what works, or doesn't, for them.
Because of that, treatment is usually based on female-only studies.
FDA wants more men included in breast cancer trials